title: Right dorsal colitis.
abstract: Moderate to severe ulcerative colitis of the right dorsal colon was diagnosed by necropsy or by exploratory celiotomy and biopsy in 13 horses with a primary clinical complaint of either colic, diarrhea, or weight loss. Clinical signs varied from acute fulminating diarrhea (possibly with fever), colic, dehydration, endotoxic shock and death, to a chronic condition manifested by mild intermittent colic up to several months in duration, and weight loss with or without mild diarrhea. In a large percentage of the horses, those affected had been hypovolemic and received nonsteroidal anti-inflammatory drugs (NSAID) or had received inappropriately high doses of phenylbutazone before the onset of illness. Experimental treatment of two horses with high doses of a phenylbutazone oral paste preparation (6 gm once daily for 5 days) and limitation of their water intake to approximately one half of maintenance requirement (for 5 days) resulted in reproduction of ulcerative colitis involving only the right dorsal colon, which was apparent at necropsy examination 11 and 15 days after initiation of drug use. It was concluded that localized ulcerative lesions in the right dorsal colon may be a previously unreported manifestation of toxicity due to the administration of NSAID.
authors: Department of Clinical Sciences, New York State College of Veterinary Medicine, Cornell University, Ithaca.
authors: L F
authors: LF
authors: Karcher
authors: S G
authors: SG
authors: Dill
authors: W I
authors: WI
authors: Anderson
authors: J M
authors: JM
authors: King
mesh_terms: D000818:Animals; D003002:Clonixin / Q000009:adverse effects / Q000031:analogs & derivatives; D003085:Colic / Q000662:veterinary; D003093:Colitis, Ulcerative / Q000139:chemically induced / Q000473:pathology / Q000662:veterinary*; D003106:Colon / Q000473:pathology*; D003967:Diarrhea / Q000662:veterinary; D005260:Female; D006734:Horse Diseases / Q000139:chemically induced / Q000473:pathology*; D006736:Horses; D008297:Male; D010653:Phenylbutazone / Q000009:adverse effects; D015431:Weight Loss
chemical_list: C014558:flunixin meglumine; D010653:Phenylbutazone; D003002:Clonixin